HAV Vaccination Is Highly Immunogenic For Virologically Suppressed Patients With HIV Infection, Those On Immunosuppressive Monotherapy, Research Finds

November 04, 2024

Infectious Disease Advisor (11/1, Nye) reported research found that “hepatitis A virus (HAV) vaccination is highly immunogenic for virologically suppressed patients with HIV infection and for those on immunosuppressive monotherapy.” The investigators said, “Simultaneous vaccination with pneumococcal conjugate vaccines seems to be detrimental for the antibody response to hepA vaccination.” The findings were published in the Journal of Travel Medicine.